UNAIDS: Funding Cuts Pose ‘Perilous Risks’ for HIV Response 25/11/2025 Kerry Cullinan Abrupt funding cuts have resulted in “perilous risks” for the global HIV response that threaten the health and well-being of millions of people throughout the world, according to the 2025 UNAIDS report released on Tuesday. “People living with HIV have died due to service disruptions, millions of people at high risk of acquiring HIV have […] Continue reading -> Global Fund Raises $11.4 Billion, Including $4.6 Billion From United States 21/11/2025 Kerry Cullinan JOHANNESBURG – The United States pledged $4.6 billion to the Global Fund during its eighth Replenishment Summit in Johannesburg on Friday – a reduction from its previous pledge of $6 billion, but also an indication that it has not abandoned all multilateral global health efforts. The Global Fund has now raised $11,4 billion of its […] Continue reading -> South Africa May Be Excluded From Future US Grants for HIV Amid Political Row 21/11/2025 Kerry Cullinan The United States (US) government has not sought a meeting with South Africa to discuss the resumption of its HIV grant, and it won’t supply the country with the long-acting HIV prevention medication, lenacapavir, amid a deepening political row between the two countries. While US Ambassadors throughout the continent have initiated meetings with African Health […] Continue reading -> Global Fund Seeks $14 Billion at Replenishment Summit – With Progress Against HIV, TB and Malaria at Risk 20/11/2025 Kerry Cullinan JOHANNESBURG – The Global Fund (GF) has only raised $4 billion of its $18 billion budget for the next three years – so much is riding on its Replenishment Summit in Johannesburg on Friday (21 November) as it seeks the balance to advance progress against HIV, tuberculosis (TB) and malaria. The United States has been […] Continue reading -> Investing in the Global Fund is Smart Economics, Not Charity 20/11/2025 Duma Gideon Boko The Global Fund to Fight AIDS, Tuberculosis and Malaria provides nearly 60% of international financing for malaria. Ahead of its Replenishment campaign on Friday, the President of Botswana appeals for world leaders to continue to support the Fund. As President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), I […] Continue reading -> Former DOGE Official Driving US Bilateral Health Agreements With African Countries 17/11/2025 Kerry Cullinan The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”. Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer […] Continue reading -> Exploring New Frontiers in the Fight Against Malaria 17/11/2025 Aden Duale, Cristina Donini, Daniel Inaoka, Kenji Takaya & Michael Adekunle Charles This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading -> South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Raises $11.4 Billion, Including $4.6 Billion From United States 21/11/2025 Kerry Cullinan JOHANNESBURG – The United States pledged $4.6 billion to the Global Fund during its eighth Replenishment Summit in Johannesburg on Friday – a reduction from its previous pledge of $6 billion, but also an indication that it has not abandoned all multilateral global health efforts. The Global Fund has now raised $11,4 billion of its […] Continue reading -> South Africa May Be Excluded From Future US Grants for HIV Amid Political Row 21/11/2025 Kerry Cullinan The United States (US) government has not sought a meeting with South Africa to discuss the resumption of its HIV grant, and it won’t supply the country with the long-acting HIV prevention medication, lenacapavir, amid a deepening political row between the two countries. While US Ambassadors throughout the continent have initiated meetings with African Health […] Continue reading -> Global Fund Seeks $14 Billion at Replenishment Summit – With Progress Against HIV, TB and Malaria at Risk 20/11/2025 Kerry Cullinan JOHANNESBURG – The Global Fund (GF) has only raised $4 billion of its $18 billion budget for the next three years – so much is riding on its Replenishment Summit in Johannesburg on Friday (21 November) as it seeks the balance to advance progress against HIV, tuberculosis (TB) and malaria. The United States has been […] Continue reading -> Investing in the Global Fund is Smart Economics, Not Charity 20/11/2025 Duma Gideon Boko The Global Fund to Fight AIDS, Tuberculosis and Malaria provides nearly 60% of international financing for malaria. Ahead of its Replenishment campaign on Friday, the President of Botswana appeals for world leaders to continue to support the Fund. As President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), I […] Continue reading -> Former DOGE Official Driving US Bilateral Health Agreements With African Countries 17/11/2025 Kerry Cullinan The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”. Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer […] Continue reading -> Exploring New Frontiers in the Fight Against Malaria 17/11/2025 Aden Duale, Cristina Donini, Daniel Inaoka, Kenji Takaya & Michael Adekunle Charles This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading -> South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa May Be Excluded From Future US Grants for HIV Amid Political Row 21/11/2025 Kerry Cullinan The United States (US) government has not sought a meeting with South Africa to discuss the resumption of its HIV grant, and it won’t supply the country with the long-acting HIV prevention medication, lenacapavir, amid a deepening political row between the two countries. While US Ambassadors throughout the continent have initiated meetings with African Health […] Continue reading -> Global Fund Seeks $14 Billion at Replenishment Summit – With Progress Against HIV, TB and Malaria at Risk 20/11/2025 Kerry Cullinan JOHANNESBURG – The Global Fund (GF) has only raised $4 billion of its $18 billion budget for the next three years – so much is riding on its Replenishment Summit in Johannesburg on Friday (21 November) as it seeks the balance to advance progress against HIV, tuberculosis (TB) and malaria. The United States has been […] Continue reading -> Investing in the Global Fund is Smart Economics, Not Charity 20/11/2025 Duma Gideon Boko The Global Fund to Fight AIDS, Tuberculosis and Malaria provides nearly 60% of international financing for malaria. Ahead of its Replenishment campaign on Friday, the President of Botswana appeals for world leaders to continue to support the Fund. As President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), I […] Continue reading -> Former DOGE Official Driving US Bilateral Health Agreements With African Countries 17/11/2025 Kerry Cullinan The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”. Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer […] Continue reading -> Exploring New Frontiers in the Fight Against Malaria 17/11/2025 Aden Duale, Cristina Donini, Daniel Inaoka, Kenji Takaya & Michael Adekunle Charles This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading -> South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Seeks $14 Billion at Replenishment Summit – With Progress Against HIV, TB and Malaria at Risk 20/11/2025 Kerry Cullinan JOHANNESBURG – The Global Fund (GF) has only raised $4 billion of its $18 billion budget for the next three years – so much is riding on its Replenishment Summit in Johannesburg on Friday (21 November) as it seeks the balance to advance progress against HIV, tuberculosis (TB) and malaria. The United States has been […] Continue reading -> Investing in the Global Fund is Smart Economics, Not Charity 20/11/2025 Duma Gideon Boko The Global Fund to Fight AIDS, Tuberculosis and Malaria provides nearly 60% of international financing for malaria. Ahead of its Replenishment campaign on Friday, the President of Botswana appeals for world leaders to continue to support the Fund. As President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), I […] Continue reading -> Former DOGE Official Driving US Bilateral Health Agreements With African Countries 17/11/2025 Kerry Cullinan The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”. Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer […] Continue reading -> Exploring New Frontiers in the Fight Against Malaria 17/11/2025 Aden Duale, Cristina Donini, Daniel Inaoka, Kenji Takaya & Michael Adekunle Charles This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading -> South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Investing in the Global Fund is Smart Economics, Not Charity 20/11/2025 Duma Gideon Boko The Global Fund to Fight AIDS, Tuberculosis and Malaria provides nearly 60% of international financing for malaria. Ahead of its Replenishment campaign on Friday, the President of Botswana appeals for world leaders to continue to support the Fund. As President of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA), I […] Continue reading -> Former DOGE Official Driving US Bilateral Health Agreements With African Countries 17/11/2025 Kerry Cullinan The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”. Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer […] Continue reading -> Exploring New Frontiers in the Fight Against Malaria 17/11/2025 Aden Duale, Cristina Donini, Daniel Inaoka, Kenji Takaya & Michael Adekunle Charles This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading -> South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Former DOGE Official Driving US Bilateral Health Agreements With African Countries 17/11/2025 Kerry Cullinan The United States government is moving rapidly to secure Memorandums of Understanding (MOU) with African countries that offer limited health aid for five years in exchange for 25 years’ access to countries’ data about “pathogens with epidemic potential”. Some commentators have described the terms of the bilateral MOUs as “extractive” as they fail to offer […] Continue reading -> Exploring New Frontiers in the Fight Against Malaria 17/11/2025 Aden Duale, Cristina Donini, Daniel Inaoka, Kenji Takaya & Michael Adekunle Charles This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading -> South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exploring New Frontiers in the Fight Against Malaria 17/11/2025 Aden Duale, Cristina Donini, Daniel Inaoka, Kenji Takaya & Michael Adekunle Charles This week, the world marks World Antimicrobial Awareness Week and malaria parasites, though often forgotten, are part of the range of microbes preventing us from achieving the Sustainable Development Goal of Good Health and Well-being. Malaria remains an immense public health burden, especially in Africa. It mainly affects the poor, and remains an immense health […] Continue reading -> South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa Launches Trial of First African-Made Cholera Vaccine 13/11/2025 Kerry Cullinan South Africa aims to become the first African country to manufacture a cholera vaccine with the launch this week of a clinical trial of an oral vaccine developed by local company Biovac. The vaccine candidate was developed thanks to a technology transfer partnership between Biovac and the International Vaccine Institute in South Korea in 2022. […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Aid Cuts Jeopardise 2024’s Slight Global Progress Against Tuberculosis 12/11/2025 Kerry Cullinan Last year, the global battle to reduce tuberculosis infections and deaths showed small signs of recovery following three disruptive COVID-19 years – but this year’s precipitous drop in development aid is likely to cause new setbacks, according to the World Health Organization (WHO). TB killed 1.23 million people in 2024 and made 10.7 million people […] Continue reading -> Posts navigation Older postsNewer posts